Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Critical Issues of Pharmaceutical Industry: A Case Study of Recent Advance in the Chemical Synthesis of Tamiflu

Wang-Kin Chiu and Yui Yip Lau

Primary manufacturing is one of the key components in a standard pharmaceutical supply chain. The primary manufacturing site is responsible for the synthesis of the active ingredient of a drug. In the manufacture or design of new synthetic routes of a drug, the logistics cost, availability of starting materials, number of steps and overall yield are critical factors to be taken into account. In view of the importance of oseltamivir phosphate (Tamiflu) in treatment of influenza, related issues and development in pharmaceutical industry should be addressed and updated. In this paper, we will (1) highlight the concepts of Supply Chain Management (SCM) in pharmaceutical industry; (2) describe the recent advance in the synthetic chemistry of Tamiflu, focusing on the new approaches based on inexpensive starting materials. This paper should be of interest to health care study and is expected to provide insights for the drug and supply chain management industry.